Temporal Lobe Epilepsy
16
4
4
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.3%
1 terminated out of 16 trials
87.5%
+1.0% vs benchmark
13%
2 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (16)
Changes in Attentional Control After a Focal Seizure.
Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging
The GABAergic Inhibitory System in Drug Resistant Epilepsy
Stereotactic Laser Ablation for Temporal Lobe Epilepsy (Slate)
Transcranial Electrical Stimulation Targeting the Cerebellum for the Treatment of Refractory Temporal Lobe Epilepsy
Intensive Preoperative Speech Rehabilitation in Drug-Resistant Temporal Epilepsy
Autonomic Dysfunction in Temporal Lobe Epilepsy and SUDEP
Exercise for Brain Regeneration in Epilepsy
Minimally Invasive Surgical Epilepsy Trial for Temporal Lobe Epilepsy
Closed Loop Auditory Stimulus in Sleep and epilepsY
Subcutaneous EEG in Epilepsy
Advanced Magnetic Resonance Imaging in Temporal Lobe Epilepsy
Electrical Brain Stimulation to Reduce Epileptic Seizures
Application of Diffusion Tensor Imaging and Tractography in Epilepsy Surgery
A Multicenter Study of Hippocampal Electrical Stimulation (HS, in Mesial Temporal Lobe Epilepsy
Escitalopram Treatment of Major Depression in Patients With Temporal Lobe Epilepsy